Bilateral Breast Cancer, also known as bilateral breast carcinoma, is related to breast-ovarian cancer, familial 2 and ataxia-telangiectasia. An important gene associated with Bilateral Breast Cancer is BRCA2 (BRCA2 DNA Repair Associated), and among its related pathways/superpathways are Infectious disease and ERK Signaling. The drugs Trastuzumab and Adenosine have been mentioned in the context of this disorder. Affiliated tissues include breast and lymph node, and related phenotypes are Decreased viability and Synthetic lethal with MLN4924 (a NAE inhibitor)